BioPorto investor relations material

Listen to the latest call from BioPorto

BioPorto A/S is a global biotech company that specializes in the development and manufacturing of in-vitro diagnostic tests and antibodies for both research and clinical applications. The company's diagnostics products are primarily based on a patented proprietary technology platform called MoAb®. The Company's products are used in research, including preclinical studies and clinical trials, as well as in diagnosis procedures to detect infectious diseases, cancer, autoimmune disorders and other diseases. BioPorto A/S is based in Hellerup, Denmark.

  • Ticker

    BIOPOR
  • Country

    DK

Dig deeper into the BioPorto fundamentals on Quartr.